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General Information. 
All reactions were carried out in dry glassware under an argon atmosphere 
using standard Schlenk techniques or in a Vacuum Atmospheres Glovebox under a 
nitrogen atmosphere, unless otherwise specified. All solvents were purified by 
passage through solvent purification columns and further degassed by bubbling 
argon. C6D6 was purified by passage through a solvent purification column. CDCl3, 
CD2Cl2 and THF-d8 were used as received.  Monomers 61 and 72 were synthesized 
according to the literature procedures, while monomer 5 was purchased from Sigma 
Aldrich and used as received. RuCl2(PCy3)(=CH-o-OiPrC6H4) (S3) was obtained from 
Materia, Inc. 2-Bromo-N-(2-iso-propyl-6-methylphenyl)acetamide (S5)3 and 1-tert-
butyl-3-mesityl-4,5-dihydro-1H-imidazol-3-ium (S2)4 were synthesized according 
to literature procedures. Silica gel was dried under vacuum at 200 °C for 48 h prior 
to use in the glovebox. Other commercially available reagents were used as received. 
1H NMR spectra were acquired at 500 MHz and 13C NMR spectra at 126 MHz 
as CDCl3 or C6D6 solutions unless otherwise noted. Chemical shifts are reported in 
ppm downfield from Me4Si by using the residual solvent peak as an internal 
standard. Spectra were analyzed and processed using MestReNova Ver. 7.1.  
High-resolution mass spectra (HRMS) were provided by the California 
Institute of Technology Mass Spectrometry Facility using a JEOL JMS-600H High 
Resolution Mass Spectrometer. All HRMS were by FAB+ ionization, except where 
specified. 
Polymer molecular weights were determined by multi-angle light scattering 
(MALS) gel permeation chromatography (GPC) using a miniDAWN TREOS light 
scattering detector, a Viscostar viscometer, and an OptilabRex refractive index 
detector, all from Wyatt Technology. An Agilent 1200 UV-Vis detector was also 
                                                        
1 Tabor, D.C.; White, F.H.; Collier, L.W.; Evans, S.A. J. Org. Chem. 1983, 48, 1638. 
2 (a) O’Dell, R.; McConville, D. H.; Hofmeister, G. E.; Schrock, R. R. J. Am. Chem. Soc. 
1994, 116, 3414. (b) Maier, G.; Jung, W. A. Chem. Ber. 1982, 125, 804. 
3 Rosebrugh, L. M.; Herbert, M. B.; Marx, V. M.; Keitz, B. K.; Grubbs, R. H. J. Am. Chem. 
Soc. 2013, 135, 1276. 
4 Ledoux, N.; Allaert, B.; Pattyn, S.; Vander Mierde, H.; Vercaemst, C.; Verpoort, F. 
Chem. Eur. J. 2006, 12, 4654. 
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present in the detector stack. Absolute molecular weights were determined using 
dn/dc values calculated by assuming 100% mass recovery of the polymer sample 
injected into the GPC. No internal standards were used. Differential Scanning 
Calorimetry (DSC) was performed using a Perkin Elmer DSC 7 at a nitrogen flow 
rate of 40 mL/min and a heating rate of 2 K/min-1 from 0 °C to 200 °C.  
Thermogravimetric analysis (TGA) was performed using a TA Instruments O5000 
TGA at a nitrogen flow rate of 10 mL/min (sample) and 25 mL/min (balance). 
 
 
Preparation of S1. 
In a glovebox, a solution of S2 (0.19 g, 0.66 mmol) in hexanes (20 mL) was 
treated with KCOMe2Et (88 mg, 0.69 mmol), and the mixture was allowed to stir at 
room temperature for 2 h. To the reaction mixture was then added S3 (0.38 g, 0.64 
mmol), upon which the mixture was removed from the glove box and allowed to stir 
at 65 °C overnight (12 h). The precipitated solids were filtered and washed well 
with warm hexanes and pentane, and then collected with CH2Cl2 and concentrated. 
The crude mixture was further purified by flash column chromatography (SiO2, 
eluent pentane to 20% Et2O in pentane to CH2Cl2) to provide S1 as a green powder. 
1H NMR (500 MHz, CDCl3) δ 16.87 (s, 1H), 7.56 (m, 1H), 7.07 (s, 2H), 6.97–6.89 (m, 
3H), 6.87 (m, 1H), 5.08 (hept, J = 6.2 Hz, 1H), 4.10–3.82 (m, 4H), 2.46 (s, 3H), 2.26–
2.27 (m, 15H), 1.62 (d, J = 6.2 Hz, 6H). 13C NMR (126 MHz, CDCl3) δ 312.9, 207.5, 
152.6, 145.7, 139.4, 138.6, 138.2, 130.9, 129.7, 124.0, 122.8, 113.3, 74.5, 56.3, 51.6, 
46.1, 29.8, 22.5, 21.3, 18.4. HRMS (FAB+): Calculated—564.1249, Found—564.1268. 
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Preparation of 2. 
In a glovebox, a 20 mL scintillation vial was charged with S1 (0.11 g, 0.20 
mmol), NaOPiv (0.25 g, 2.0 mmol), THF (4.0 mL), and MeOH (2.0 mL). The vial was 
capped, removed from the glovebox, and heated to 40 °C for 5 h at which point a 
color change from green to brown to dark purple was observed. The vial was 
returned to the box, where the solvent was removed under high vacuum and the 
residue dissolved in CH2Cl2 (30 mL), filtered through celite, and concentrated to a 
deep purple residue. The crude mixture was purified by pipette column (SiO2, eluent 
20% Et2O in pentane) three times and subsequently recrystallized from pentane to 
provide 2 as a bright purple solid (59 mg, 22%). 1H NMR (500 MHz, THF-d8) δ 14.69 
(s, 1H), 7.44–7.36 (m, 1H), 7.32 (m, 1H), 7.07 (m, 1H), 6.88 (m, 1H), 6.72 (s, 2H), 5.04 
(hept, J = 6.2 Hz, 1H), 3.95–3.72 (m, 4H), 2.82 (d, J = 10 Hz, 1H), 2.38 (s, 3H), 2.38 
(overlapped, 1H), 2.14 (s, 3H), 2.13 (s, 3H), 1.45 (d, J = 6.2 Hz, 3H), 1.44 (s, 3H), 1.38 
(d, J = 6.2 Hz, 3H), 0.87 (s, 9H), 0.57 (s, 3H). 13C NMR (126 MHz, CD2Cl2) δ 260.3, 
211.4, 188.2, 155.0, 143.7, 137.9, 137.6, 137.0, 136.8, 129.9, 129.2, 126.2, 123.4, 
122.7, 114.1, 75.8, 62.6, 51.1, 47.7, 43.9, 39.6, 29.4, 28.1, 23.2, 22.2, 22.0, 21.1, 18.8, 
18.7. HRMS (FAB+, (M+H)-H2): Calculated—593.2318, Found—593.2327. 
 
 
Preparation of 2-(tert-butylamino)-N-(2-isopropyl-6-methylphenyl)acetamide 
(S4).  
S5 (7.2 g, 27 mmol) and tert-butylamine (4.2 mL, 39 mmol) were dissolved in 
MeCN (90 mL), K2CO3 (5.7 g, 42 mmol) was added, and the solution was refluxed for 
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O
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24 h. After cooling to room temperature, the mixture was filtered over celite and 
concentrated. The residue was then dissolved in CH2Cl2 and filtered over a pad of 
silica gel (eluent 10% MeOH in CH2Cl2). Removal of the solvent in vacuo provided S4 
(6.7 g, 94%) as an off-white solid. 1H NMR (500 MHz, CDCl3) δ 9.09 (br s, 1H), 7.18 
(m, 1H), 7.16 (m, 1H), 7.09 (m, 1H), 3.41 (s, 2H), 3.03 (m, 1H), 2.22 (s, 3H), 1.71 (br 
s, 1H), 1.20 (d, J = 6.9 Hz, 6H), 1.17 (s, 9H). 13C NMR (126 MHz, CDCl3) δ 171.6, 145.2, 
135.6, 132.8, 128.2, 127.5, 123.4, 51.3, 46.1, 29.1, 28.7, 23.4, 18.8. HRMS (FAB+, 
(M+H)): Calculated—263.2123, Found—263.2111. 
 
 
Preparation of N1-(tert-butyl)-N2-(2-isopropyl-6-methylphenyl)ethane-1,2-
diamine (S6).  
A solution of compound S4 (6.7 g, 26 mmol) in THF (10 mL) was added to a 0 
°C solution of lithium aluminum hydride (3.0 g, 79 mmol)  in THF (100 mL), and the 
solution was brought to room temperature, then refluxed for 72 h. The mixture was 
then cooled to 0 °C, and water (3 mL), 10% aq. NaOH (3 mL), then additional water 
(3 mL) were added sequentially. The solution was dried with MgSO4, filtered, and 
concentrated. Flash chromatography of the residue (SiO2, using 10% MeOH in 
CH2Cl2) provided S6 (3.7 g, 57%) as a pale yellow oil. 1H NMR (500 MHz, CDCl3) δ 
7.09 (m, 1H), 6.98 (m, 1H), 6.91 (m, 1H), 3.29 (m, 1H), 3.00 (m, 2H), 2.80 (m, 2H), 
2.33 (s, 3H), 1.24 (d, J = 6.9 Hz, 6H), 1.13 (s, 9H). 13C NMR (126 MHz, CDCl3) δ 145.2, 
140.7, 130.5, 128.4, 123.6, 122.4, 50.6, 50.3, 42.8, 29.2, 27.5, 24.0, 19.0. HRMS 
(FAB+, (M+H)): Calculated—249.2331, Found—249.2335. 
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Preparation of 3-(tert-Butyl)-1-(2-isopropyl-6-methylphenyl)-4,5-dihydro-1H-
imidazol-3-ium chloride  (S7).  
A solution of compound S6 (3.5 g, 14 mmol) in Et2O (25 mL) was treated 
with HCl (14 mL, 2 M in Et2O), and stirred for 15 minutes at room temperature. The 
solid was then filtered, washed with Et2O, dried, suspended in CH(OEt)3 (25 mL), 
and refluxed for 2 h. The solution was cooled to room temperature, and then 
concentrated. The resulting solid residue was washed rigorously with Et2O to 
provide S7 (1.5 g, 37%) as an off-white solid. 1H NMR (500 MHz, CDCl3) δ 9.02 (br s, 
1H), 7.31 (m, 1H), 7.22 (m, 1H), 7.12 (m, 1H), 4.49 (m, 1H), 4.38 (m, 2H), 4.22 (m, 
1H), 2.91 (m, 1H), 2.40 (s, 3H), 1.61 (s, 9H), 1.27 (m, 6H). 13C NMR (126 MHz, CDCl3) 
δ 157.0, 146.4, 135.9, 132.0, 130.5, 129.2, 124.8, 57.8, 52.4, 46.5, 28.6, 28.4, 24.8, 
24.2, 18.6. HRMS (FAB+, (M-Cl)): Calculated—259.2174, Found—259.2172.  
 
 
Preparation of S8.  
In a glovebox, KCOMe2Et (0.15 g, 1.2 mmol) was added to a suspension of 
compound S7 (0.29 g, 1.0 mmol) in hexanes (12 mL). The solution was stirred at 35 
°C for 30 minutes, and then S3 (0.60 g, 1.0 mmol) was added, and then removed 
from the glovebox. The solution was stirred for 3 h at 65 °C and subsequently cooled 
to room temperature. The resulting precipitate was filtered, washed with warm 
hexanes, and further purified by column chromatography  (SiO2, eluent pentane to 
20% Et2O in pentane to DCM) to provide S8 (0.55 g, 92%) as a green solid. 1H NMR 
(500 MHz, CDCl3) δ 16.86 (s, 1H), 7.54 (m, 1H), 7.49 (m, 1H), 7.41 (m, 1H), 7.23 (m, 
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1H), 6.94 (m, 1H), 6.88 (m, 1H), 6.85 (m, 1H), 5.07 (hept, J = 6.2 Hz, 1H), 4.02 (m, 
2H), 3.91 (m, 2H), 3.17 (hept, J = 6.8 Hz, 1H), 2.33 (s, 3H), 2.28 (s, 9H), 1.67 (d, J = 6.2 
Hz), 1.59 (d, J = 6.2 Hz, 3H), 1.19 (d, J = 6.8 Hz, 3H), 0.89 (d, J = 6.8 Hz, 3H). 13C NMR 
(126 MHz, CDCl3) δ 311.0, 207.8, 152.7, 148.8, 145.0, 140.4, 138.0, 130.7, 129.1, 
129.0, 124.8, 123.9, 122.6, 113.2, 74.5, 56.3, 53.1, 46.0, 29.8, 27.6, 25.6, 23.8, 22.7, 
22.3, 19.0. HRMS (FAB+, (M)): Calculated—578.1405, Found—578.1433. 
 
 
Preparation of 3.  
In a glovebox, a solution of sodium pivalate (0.22 g, 1.7 mmol) in MeOH (3 
mL) was added to a solution of compound S8 (0.10 g, 0.17 mmol) in THF (6 mL). 
The mixture was removed from the glovebox, heated at 50 °C for 12 h, and then 
brought back into the glovebox and concentrated. The residue was dissolved in 
CH2Cl2, filtered over a pad of celite, and concentrated. The crude mixture was 
subjected to purification over a plug of silica gel (eluent pentanes to 20% Et2O in 
pentanes), then recrystallized from hexanes to provide 6 (65 mg, 65%) as a bright 
purple solid. 1H NMR (500 MHz, CD2Cl2) δ 14.70 (s, 1H), 7.45 (m, 1H), 7.39 (m, 1H), 
7.08 (m, 1H), 7.07 (m, 1H), 7.02 (m, 1H), 6.94 (m, 1H), 4.99 (hept, J = 6.4 Hz), 3.92–
3.79 (m, 3H), 3.79–3.69 (m, 2H), 2.79 (d, J = 6.8 Hz, 1H), 2.45 (d, J = 6.8 Hz, 1H), 2.17 
(s, 3H), 1.47 (s, 3H), 1.44 (d, J = 6.4 Hz), 1.40 (d, J = 6.4 Hz, 3H), 1.24 (d, J = 6.9 Hz, 
3H), 1.10 (d, J = 6.9 Hz, 3H), 0.91 (s, 9H), 0.56 (s, 3H). 13C NMR (126 MHz, CD2Cl2) δ 
260.2, 210.9, 187.5, 154.5, 147.5, 143.2, 138.4, 137.5, 128.3, 127.5, 125.6, 123.8, 
122.9, 122.3, 113.8, 75.5, 62.1, 51.8, 47.3, 43.4, 39.1, 28.8, 27.9, 27.7, 25.5, 23.7, 22.8, 
21.8, 21.7, 18.7. HRMS (FAB+, (M)): Calculated—608.2552, Found—608.2536. 
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Preparation of N-(tert-Butyl)-2-((2-isopropyl-6-methylphenyl)amino)-2-
methylpropanamide (S9).  
2-Bromo-2-methylpropionyl bromide (4.1 g, 33 mmol) was dissolved in 
CH2Cl2 (60 mL), tert-butylamine (3.2 mL, 30 mmol) followed by Et3N (12 mL, 60 
mmol) were added dropwise, and the mixture was stirred overnight at room 
temperature. The solution was washed with saturated NH4Cl (aq.) (x2), dried with 
Na2SO4, and concentrated. The residue was then dissolved in THF (75 mL), 
cannulated into a solution of 2-isopropyl-6-methylaniline (5.0 g, 33 mmol) and NaH 
(1.4 g, 60 mmol) in THF (75 mL), and stirred overnight at room temperature. The 
solution was diluted with EtOAc, washed with saturated NH4Cl (aq.), brine, and 
dried with Na2SO4, and concentrated. Purification by column chromatography (SiO2, 
eluent 10% MeOH in CH2Cl2) and removal of the solvent in vacuo provided S9 (2.9 g, 
33%) as a peach solid. 1H NMR (500 MHz, CDCl3) δ 7.83 (br s, 1H), 7.10 (m, 1H), 6.98 
(m, 2H), 3.17 (br s, 1H), 3.11 (m, 1H), 2.27 (s, 3H), 1.40 (s, 9H), 1.30 (s, 6H), 1.20 (d, J 
= 6.9 Hz, 6H). 13C NMR (126 MHz, CDCl3) δ 176.9, 143.4, 141.3, 132.7, 128.5, 124.1, 
123.7, 60.3, 50.2, 28.5, 28.2, 27.1, 23.7, 20.7. HRMS (EI+, (M+H)): Calculated—
291.2436, Found—291.2429. 
 
 
Preparation of N1-(tert-Butyl)-N2-(2-isopropyl-6-methylphenyl)-2-
methylpropane-1,2-diamine (S10).  
A solution of BH3·THF (43 mL, 1 M in THF), was added dropwise to a 0 °C 
solution of compound S9 (2.5 g, 8.6 mmol) in THF (12 mL). The mixture was stirred 
overnight at room temperature, and then quenched via dropwise addition of MeOH 
at 0 °C and concentrated.  The residue was then re-dissolved in MeOH and re-
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concentrated (x3). Purification by column chromatography (SiO2, eluent CH2Cl2 then 
10% MeOH in CH2Cl2) and removal of the solvent in vacuo provided S10 (1.2 g, 
50%) as a colorless oil. 1H NMR (500 MHz, CDCl3) δ 7.09 (m, 1H), 7.00 (m, 1H), 6.97 
(m, 1H), 3.53 (m, 1H), 2.60 (2, 2H), 2.37 (s, 3H), 1.18 (d, J = 6.9 Hz, 6H), 1.15 (s, 9H), 
1.06 (s, 6H). 13C NMR (126 MHz, CDCl3) δ 145.5, 142.6, 135.2, 128.1, 123.4, 123.2, 
56.0, 54.9, 49.9, 29.3, 27.5, 26.7, 24.1, 20.8. HRMS (EI+, (M+H)): Calculated—
277.2644, Found—277.2636. 
 
 
Preparation of 3-(tert-Butyl)-1-(2-isopropyl-6-methylphenyl)-5,5-dimethyl-
4,5-dihydro-1H-imidazol-3-ium chloride (S11).  
A solution of compound S10 (1.1 g, 4.0 mmol) in Et2O (10 mL) was treated 
with HCl (4.0 mL, 2 M in Et2O), and stirred for 15 minutes at room temperature. The 
solid was then filtered, washed with Et2O, dried, suspended in CH(OEt)3 (10 mL), 
and refluxed for 2 h. The solution was cooled to room temperature, and then 
concentrated. The resulting solid residue was washed rigorously with Et2O to 
provide S11 (0.6 g, 46%) as a colorless solid. 1H NMR (500 MHz, CDCl3) δ 9.26 (br s, 
1H), 7.30 (m, 1H), 7.21 (m, 1H), 7.13 (m, 1H), 4.07 (d, J = 12 Hz, 1H), 4.02 (d, J = 12 
Hz, 1H), 2.85 (m, 1H), 2.41 (s, 3H), 1.60 (s, 9H), 1.48 (s, 3H), 1.41 (s, 3H), 1.29 (d, J = 
6.8 Hz, 3H), 1.16 (d, J = 6.8 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 156.7, 148.3, 137.8, 
130.3, 129.7, 128.9, 124.7, 69.7, 58.7, 57.8, 29.2, 28.3, 26.9, 26.4, 25.9, 22.7, 20.5. 
HRMS (FAB+, (M-Cl)): Calculated—287.2487, Found—287.2499. 
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Preparation of S12. 
In a glovebox, KCOMe2Et (57 mg, 0.45 mmol) was added to a suspension of 
compound S11 (0.14 g, 0.43 mmol) in hexanes (13 mL). The solution was stirred at 
room temperature for 2 h, and then S3 (0.31 g, 0.52 mmol) was added, at which 
point the solution was removed from the glovebox. The solution was stirred for 3 h 
at 65 °C and then cooled to room temperature. The resulting precipitate was 
filtered, washed thoroughly with warm hexanes, and further purified by column 
chromatography  (SiO2, eluent pentane to 20% Et2O in pentane to CH2Cl2) to provide 
S12 (0.21 g, 86%) as a green solid. 1H NMR (500 MHz, CDCl3) δ 16.66 (s, 1H), 7.57–
7.42 (m, 3H), 7.24–7.20 (m, 1H), 6.93 (d, J = 8.4 Hz, 1H), 6.90–6.83 (m, 2H), 5.06 
(hept, J = 6.3 Hz, 1H), 3.84 (d, J = 9.9 Hz, 1H), 3.65 (d, J = 9.8 Hz, 1H), 3.25 (hept, J = 
6.7 Hz, 1H), 2.29 (overlapped, 12H), 1.68 (d, J = 6.2 Hz, 3H), 1.58 (d, J = 6.2 Hz, 3H), 
1.40 (s, 3H), 1.24 (d, J = 6.8 Hz, 3H), 1.12 (s, 3H), 0.75 (d, J = 6.6 Hz, 3H). 13C NMR 
(126 MHz, CDCl3) δ 310.79, 207.99, 152.78, 150.31, 144.75, 140.38, 138.56, 130.61, 
129.54, 128.67, 125.33, 124.12, 122.65, 113.34, 74.45, 65.40, 61.19, 56.32, 29.79, 
28.33, 27.99, 25.63, 25.26, 23.92, 22.86, 22.29, 21.32. HRMS (FAB+, (M+H)-H2): 
Calculated—605.1640, Found—605.1618. 
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Preparation of 4. 
In a glovebox, a 20 ml scintillation vial was charged with S12 (60 mg, 0.10 
mmol), NaOPiv (0.12 g, 1.0 mmol), THF (2.0 mL), and MeOH (2.0 mL). The vial was 
capped, removed from the glovebox, and heated to 40 °C for 21 h at which point a 
color change from green to brown to dark purple was observed. The vial was 
returned to the box, where the solvent was removed under high vacuum and the 
residue dissolved in CH2Cl2 (15 mL), filtered through celite, and concentrated to a 
deep purple residue. The residue was purified by pipet column (SiO2, eluent 20% 
Et2O in pentane) and subsequently recrystallized from hexanes to provide 8 as a 
bright purple solid (25 mg, 40%). 1H NMR (500 MHz, C6D6) δ 14.98 (s, 1H), 7.47 (dd, 
J = 7.4, 1.7 Hz, 1H), 7.23 (td, J = 8.0, 1.7 Hz, 1H), 7.07 (overlapped, 2H), 6.97–6.99 (m, 
1H), 6.88 (t, J = 7.4 Hz, 1H), 6.60 (d, J = 8.3 Hz, 1H), 4.63 (hept, J = 6.3 Hz, 1H), 3.98 
(hept, J = 6.8 Hz, 1H), 3.35–3.21 (m, 2H), 2.80–2.69 (m, 2H), 2.32 (s, 3H), 1.46 (d, J = 
6.4 Hz, 3H), 1.40 (s, 3H), 1.35 (s, 3H), 1.31 (d, J = 6.9 Hz, 3H), 1.24 (d, J = 6.1 Hz, 3H), 
1.18 (s, 9H), 1.12 (d, J = 6.9 Hz, 3H), 0.76 (s, 3H), 0.61 (d, J = 9.0 Hz, 3H). 13C NMR 
(126 MHz, C6D6) δ 260.95, 211.46, 187.86, 155.35, 149.68, 144.03, 139.68, 136.90, 
128.69, 127.87, 127.57, 125.73, 124.69, 123.15, 122.70, 113.79, 75.07, 64.80, 62.12, 
57.77, 47.76, 39.61, 30.87, 28.77, 28.69, 28.39, 25.63, 24.67, 24.12, 22.87, 22.01, 
21.82, 20.68. HRMS (FAB+, (M+H)-H2): Calculated—635.2787, Found—635.2788. 
 
General Procedure for the Determination of Initiation Rates.  
In a glovebox, a 4 mL vial was charged with catalyst (0.012 mmol) and 
diluted with 1 mL C6D6 to create a stock solution (0.012 M). A portion of the stock 
solution (0.25 mL, 0.003 mmol catalyst) was added to an NMR tube and diluted with 
C6D6 (0.35 mL). The NMR tube was sealed with a septa cap and placed in the NMR 
N N
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O
iPr
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spectrometer at 30 °C. Butyl vinyl ether (12 µL, 0.09 mmol) was added and the 
disappearance of the benzylidene proton resonance was monitored by arraying the 
‘pad’ function in VNMRj.  
All reactions showed clean first-order kinetics over a period of at least three 
half-lives. Spectra were baseline corrected and integrated with MestReNova. 
Estimation of error was determined from the average of three different kinetic runs. 
 
General Polymerization Procedure.  
In a glovebox, a solution of catalyst was prepared from 2 (24 mg, 40 μmol) 
and THF (6 mL) and added to a Schlenk flask. On a vacuum manifold, a separate 
Schlenk flask was flame-dried and charged with monomer (4.0 mmol) and THF (10 
mL) to make a stock solution. The monomer solution was degassed via freeze-
pump-thaw (3X). An aliquot (2.5 mL, 1.0 mmol) of monomer stock solution was 
added via gas-tight syringe to an air-tight vial with a septum cap under an argon 
balloon. An aliquot (1.5 mL, 10 μmol) of catalyst solution was then injected via gas-
tight syringe. After stirring for 1 h at room temperature, the polymerization was 
quenched with ethyl vinyl ether (0.1 mL) and precipitated into vigorously stirred 
MeOH. The precipitate was collected by vacuum filtration using either a medium or 
fine porosity frit and dried under vacuum. 
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Preparation of Poly-5 Using Catalyst 2. 
Poly-5 was prepared according to the general procedure using catalyst 2. 
NMR samples were prepared by stirring poly-5 in CDCl3. 1H and 13C NMR spectral 
assignments were consistent with literature reports.5,6 
 
 
Figure S1. 1H NMR (500 MHz, CDCl3) spectrum of poly-5 prepared with 2. 
                                                        
5 Al Samak, B.; Amir-Ebrahimi, V.; Corry, D. G.; Hamilton, J. G.; Rigby, S.; Rooney, J. J.; 
Thompson, J. M. J. Mol. Catal. A: Chem. 2000, 160, 13. 
6 Keitz, B. K.; Fedorov, A.; Grubbs, R. H. J. Am. Chem. Soc. 2012, 134, 2040. 
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Figure S2. 13C NMR (126 MHz, CDCl3) spectrum of poly-5 prepared with 2. 
 
Figure S3. 1H-13C HSQC (CDCl3) spectrum of poly-5 prepared with 2. 
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Preparation of Poly-5 Using Catalyst 3. 
Poly-5 was prepared according to the general procedure using catalyst 3. 
NMR samples were prepared by stirring poly-5 in CDCl3. 1H and 13C NMR spectral 
assignments were consistent with literature reports.5,6 
 
 
Figure S4. 1H NMR (500 MHz, CDCl3) spectrum of poly-5 prepared with 3. 
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Figure S5. 13C NMR (126 MHz, CDCl3) spectrum of poly-5 prepared with 3. 
 
Figure S6. 1H-13C HSQC (CDCl3) spectrum of poly-5 prepared with 3. 
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Preparation of Poly-5 Using Catalyst 4. 
Poly-5 was prepared according to the general procedure using catalyst 4. 
NMR samples were prepared by stirring poly-5 in CDCl3. 1H and 13C NMR spectral 
assignments were consistent with literature reports.5,6 
 
 
Figure S7. 1H NMR (500 MHz, CDCl3) spectrum of poly-5 prepared with 4. 
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Figure S8. 13C NMR (126 MHz, CDCl3) spectrum of poly-5 prepared with 4. 
 
Figure S9. 1H-13C HSQC (CDCl3) spectrum of poly-5 prepared with 4. 
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Preparation of Poly-6 with Catalyst 2. 
Poly-6 was prepared according to the general procedure using catalyst 2. 
NMR samples were prepared by stirring poly-6 in CDCl3. Samples of poly-6 
prepared using catalysts 2-4 were virtually identical by 1H and 13C NMR. All 1H and 
13C NMR spectral assignments were consistent with literature reports.6,7 
 
 
Figure S10. 1H NMR (500 MHz, CDCl3) spectrum of poly-6 prepared with 2. 
                                                        
7 (a) McConville, D. H.; Wolf, J. R.; Schrock, R. R. J. Am. Chem. Soc. 1993, 115, 4413. (b) 
Flook, M. M.; Jiang, A. J.; Schrock, R. R.; Müller, P.; Hoveyda, A. H. J. Am. Chem. Soc. 
2009, 131, 7962. 
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Figure S11. 13C NMR (126 MHz, CDCl3) spectrum of poly-6 prepared with 2. 
 
Figure S12. 1H-13C HSQC (CDCl3) spectrum of poly-6 prepared with 2.  
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Preparation of Poly-7 Using Catalyst 2. 
Poly-7 was prepared according to the general procedure using catalyst 2. 
NMR samples were prepared by stirring poly-7 in CDCl3. 1H NMR spectral 
assignments were consistent with literature data.7b 13C NMR (126 MHz, CDCl3) δ 
165.1 (CO), 164.1 (CO), 144.0 (C2 or C3), 140.1 (C2 or C3), 131.8 (C5 or C6), 131.6 (C5 
or C6), 75.3 (CO2CH), 75.0 (CO2CH), 47.0, 46.9, 46.8, 45.0 (C1 or C4), 44.7 (C1 or C4), 
41.1, 41.0, 38.5 (C7), 34.5, 31.7, 25.7, 23.3, 22.3 (Me), 22.3 (Me), 21.2 (Me), 21.1 
(Me), 16.5 (Me), 16.3 (Me). 
 
 
Figure S13. 1H NMR (500 MHz, CDCl3) spectrum of poly-7 prepared with 2. 
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Figure S14. 13C NMR (126 MHz, CDCl3) spectrum of poly-7 prepared with 2. 
 
Figure S15. 1H-13C HSQC (CDCl3) spectrum of poly-7 prepared with 2.  
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Samples of poly-7 prepared using catalysts 2-4 were virtually identical by 1H and 
13C NMR. The 1H and 13C chemical shifts of the minor compound were consistent 
with those reported for the trans, syndiotactic poly-5.2a 
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Figure S16. 1H NMR (500 MHz, THF-d8) spectrum of 2. 
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Figure S17. 13C NMR (126 MHz, CD2Cl2) spectrum of 2. 
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Figure S18. 1H NMR (500 MHz, C6D6) spectrum of 3. 
 S28
Figure S19. 13C NMR (126 MHz, C6D6) spectrum of 3. 
 S29
Figure S20. 1H NMR (500 MHz, C6D6) spectrum of 4. 
 S30
Figure S21. 13C NMR (126 MHz, C6D6) spectrum of 4. 
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Figure S22. DSC curve for cis, syndiotactic poly-5 prepared with catalyst 2. 
 
 
Figure S23. TGA curve for cis, syndiotactic poly-5 prepared with catalyst 2. 
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Figure S24. TGA curve for trans, atactic poly(norbornene) prepared with (1,3-Bis-
(2,4,6-trimethylphenyl)-2-imidazolidinylidene)dichloro(o-
isopropoxyphenylmethylene)ruthenium. 
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